U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579949) titled 'A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)' on April 23.

Brief Summary: This study is a multicenter study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of treatment with SNH-119014 in adult participants with non-transfusion-dependent thalassemia. 30 participants with non-transfusion-dependent thalassemia were enrolled.

Study Start Date: June 18

Study Type: INTERVENTIONAL

Condition: Thalassemia

Intervention: DRUG: SNH-119014 dose 1

Study Drug

DRUG: SNH-119014 dose 2

Study Drug

DRUG: Placebo

Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor:...